Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands

JM Bos; HC Rumke; R Welte; MJ Postma

doi:10.1016/S0149-2918(03)80322-3

Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands

JM Bos, HC Rumke, R Welte, MJ Postma

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

59 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2614-2630
Number of pages	17
Journal	Clinical Therapeutics
Volume	25
Issue number	10
DOIs	https://doi.org/10.1016/S0149-2918(03)80322-3
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0149-2918(03)80322-3

http://hdl.handle.net/1765/70222

Cite this

@article{49392308896947ed974d6d73939baf16,

title = "Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands",

author = "JM Bos and HC Rumke and R Welte and MJ Postma",

year = "2003",

doi = "10.1016/S0149-2918(03)80322-3",

language = "Undefined/Unknown",

volume = "25",

pages = "2614--2630",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands

AU - Bos, JM

AU - Rumke, HC

AU - Welte, R

AU - Postma, MJ

PY - 2003

Y1 - 2003

U2 - 10.1016/S0149-2918(03)80322-3

DO - 10.1016/S0149-2918(03)80322-3

M3 - Article

SN - 0149-2918

VL - 25

SP - 2614

EP - 2630

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 10

ER -